Quantitation of passively acquired human immunodeficiency virus (HIV) antibodies in AIDS patients transfused with a plasma that is rich in HIV antibodies

Transfusion

Volumn 36, Issue 8, 1996, Pages 734-738

  Lefrere J J ^a   Roudot Thoraval, F ^b   Vittecoq, D ^c   Heshmati, F ^d   Audat, F ^e   Lerable, J ^a   Reed, D ^f   Petit, J C ^g   Burghoffer, B ^g   Morand Joubert, L ^g  

^a INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔPITAL PAUL BROUSSE   (France)

^d Hôpital Cochin ^*  (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f Inst Natl de Transfusion Sanguine ^*  (Switzerland)

^g HÔPITAL SAINT ANTOINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS; IMMUNOBLOTTING; IMMUNOTHERAPY; QUANTITATIVE DIAGNOSIS;

EID: 10144232096     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36896374379.x     Document Type: Article

References (9)

1. Karpas A, Hill F, Youle M, et al. Effects of passive immunization in patients with the acquired immunodeficiency syndrome- related complex and acquired immunodeficiency syndrome. Proc Natl Acad Sci U S A 1988;85:9234-7.
2. Jackson GG, Perkins JT, Rubenis M, et al. Passive immunoneutralization of human immunodeficiency virus in patients with advanced AIDS. Lancet 1988;2:647-52.
3. Jacobson JM, Colman N, Ostrow NA, et al. Passive immunotherapy in the treatment of advanced human immunodeficiency virus infection. J Infect Dis 1993;168:298-305.
4. Levy J, Youvan T, Lee ML, et al. Passive hyperimmune plasma therapy in the treatment of acquired immunodeficiency syndrome: results of a 12-month multicenter double-blind controlled trial. The Passive Hyperimmune Therapy Study Group. Blood 1994;84:2130-5.
5. Vittecoq D, Mattlinger B, Barre-Sinoussi F, et al. Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. J Infect Dis 1992;165:364-8.
6. Vittecoq D, Chevret S, Morand-Joubert L, et al. Passive immunotherapy in AIDS: a double-blind randomized study based on transfusions of plasma rich in anti-human immunodeficiency virus 1 antibodies vs. transfusions of seronegative plasma. Proc Natl Acad Sci U S A 1995;92:1195-9.
7. Morand-Joubert L, Mariotti M, Reed D, et al. Correlation between viral DNA load and serum anti p19 antibody concentration in symptomless human T-lymphotropic virus type-I (HTLV- I)-infected individuals. Int J Cancer 1995;60:156-9.
8. Nishanian P, Huskins KR, Stehn S, et al. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J Infect Dis 1990;162:21-8.
9. Morand-Joubert L, Costagliola D, Bludau H, et al. Predicting progression of HIV disease: usefulness of acid dissociated p24 antigen. J Acquir Immune Defic Syndr 1994;7:676-80.